| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| mRNA Cleavage and Polyadenylation Factors | 38 | 2023 | 61 | 9.870 |
Why?
|
| Protein Biosynthesis | 50 | 2024 | 291 | 9.510 |
Why?
|
| RNA, Messenger | 54 | 2025 | 1467 | 8.210 |
Why?
|
| Fragile X Mental Retardation Protein | 16 | 2025 | 37 | 7.650 |
Why?
|
| Fragile X Syndrome | 12 | 2025 | 28 | 5.830 |
Why?
|
| Transcription Factors | 37 | 2023 | 1456 | 5.810 |
Why?
|
| Polyadenylation | 25 | 2023 | 44 | 5.640 |
Why?
|
| RNA-Binding Proteins | 31 | 2023 | 384 | 5.110 |
Why?
|
| Xenopus Proteins | 18 | 2012 | 34 | 4.010 |
Why?
|
| Synapses | 18 | 2017 | 177 | 3.900 |
Why?
|
| Neurons | 18 | 2024 | 856 | 3.210 |
Why?
|
| Neuronal Plasticity | 14 | 2023 | 140 | 3.200 |
Why?
|
| Hippocampus | 15 | 2020 | 238 | 3.160 |
Why?
|
| Polynucleotide Adenylyltransferase | 9 | 2022 | 14 | 2.770 |
Why?
|
| Ribosomes | 7 | 2021 | 153 | 2.740 |
Why?
|
| Oocytes | 21 | 2012 | 189 | 2.500 |
Why?
|
| Animals | 83 | 2025 | 19562 | 2.210 |
Why?
|
| Cytoplasm | 13 | 2023 | 272 | 2.150 |
Why?
|
| Trinucleotide Repeat Expansion | 5 | 2025 | 33 | 2.080 |
Why?
|
| RNA Splicing | 3 | 2025 | 161 | 1.780 |
Why?
|
| RNA Processing, Post-Transcriptional | 5 | 2020 | 87 | 1.770 |
Why?
|
| Gene Expression Regulation | 12 | 2020 | 1534 | 1.750 |
Why?
|
| Mice | 39 | 2025 | 10237 | 1.740 |
Why?
|
| Eukaryotic Initiation Factor-4E | 6 | 2009 | 16 | 1.440 |
Why?
|
| MicroRNAs | 6 | 2016 | 617 | 1.290 |
Why?
|
| Peptide Chain Initiation, Translational | 3 | 2021 | 20 | 1.230 |
Why?
|
| Cellular Senescence | 6 | 2014 | 103 | 1.180 |
Why?
|
| Long-Term Potentiation | 4 | 2020 | 43 | 1.130 |
Why?
|
| Mice, Knockout | 16 | 2024 | 1984 | 1.130 |
Why?
|
| Polyribosomes | 5 | 2020 | 14 | 1.090 |
Why?
|
| RNA | 7 | 2023 | 402 | 1.080 |
Why?
|
| Dendrites | 6 | 2017 | 56 | 1.060 |
Why?
|
| Xenopus laevis | 12 | 2009 | 66 | 0.990 |
Why?
|
| Poly A | 7 | 2022 | 27 | 0.990 |
Why?
|
| RNA Stability | 6 | 2020 | 93 | 0.940 |
Why?
|
| RNA Caps | 3 | 2009 | 17 | 0.910 |
Why?
|
| Aggrecans | 1 | 2024 | 9 | 0.910 |
Why?
|
| Xenopus | 13 | 2015 | 53 | 0.890 |
Why?
|
| Mice, Inbred C57BL | 12 | 2024 | 3183 | 0.860 |
Why?
|
| Codon | 2 | 2020 | 47 | 0.850 |
Why?
|
| Neural Stem Cells | 2 | 2021 | 43 | 0.810 |
Why?
|
| Cell Cycle Proteins | 6 | 2009 | 374 | 0.800 |
Why?
|
| Molecular Sequence Data | 15 | 2011 | 1975 | 0.770 |
Why?
|
| CDC2 Protein Kinase | 3 | 2007 | 33 | 0.760 |
Why?
|
| Humans | 45 | 2025 | 59226 | 0.750 |
Why?
|
| C9orf72 Protein | 1 | 2021 | 98 | 0.730 |
Why?
|
| Alternative Splicing | 2 | 2020 | 120 | 0.730 |
Why?
|
| Phagocytosis | 1 | 2022 | 252 | 0.730 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2020 | 9 | 0.720 |
Why?
|
| Homeostasis | 3 | 2020 | 340 | 0.690 |
Why?
|
| Cell Cycle | 6 | 2013 | 379 | 0.690 |
Why?
|
| Fibroblasts | 5 | 2012 | 366 | 0.670 |
Why?
|
| Memory | 3 | 2009 | 116 | 0.670 |
Why?
|
| Brain | 4 | 2019 | 1487 | 0.660 |
Why?
|
| Autistic Disorder | 2 | 2020 | 167 | 0.660 |
Why?
|
| Models, Biological | 11 | 2020 | 1137 | 0.650 |
Why?
|
| Microglia | 1 | 2022 | 227 | 0.650 |
Why?
|
| 3' Untranslated Regions | 8 | 2020 | 84 | 0.640 |
Why?
|
| Protein Binding | 11 | 2020 | 1544 | 0.640 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2014 | 630 | 0.620 |
Why?
|
| Adult Stem Cells | 1 | 2018 | 28 | 0.620 |
Why?
|
| Interleukin-6 | 3 | 2022 | 309 | 0.620 |
Why?
|
| Base Sequence | 9 | 2019 | 1308 | 0.610 |
Why?
|
| Neurogenesis | 1 | 2018 | 59 | 0.600 |
Why?
|
| Neurodegenerative Diseases | 2 | 2017 | 127 | 0.590 |
Why?
|
| Cyclin B | 5 | 2008 | 17 | 0.590 |
Why?
|
| Cells, Cultured | 12 | 2013 | 2100 | 0.590 |
Why?
|
| Meiosis | 4 | 2012 | 62 | 0.580 |
Why?
|
| RNA Nucleotidyltransferases | 1 | 2017 | 7 | 0.580 |
Why?
|
| Ribonucleases | 3 | 2019 | 31 | 0.580 |
Why?
|
| Carbohydrate Metabolism | 1 | 2017 | 48 | 0.570 |
Why?
|
| Transcription, Genetic | 5 | 2020 | 846 | 0.560 |
Why?
|
| Protein Isoforms | 2 | 2023 | 193 | 0.560 |
Why?
|
| Tremor | 1 | 2017 | 20 | 0.550 |
Why?
|
| RNA 3' End Processing | 1 | 2016 | 5 | 0.550 |
Why?
|
| HEK293 Cells | 4 | 2022 | 568 | 0.550 |
Why?
|
| Phosphorylation | 10 | 2012 | 861 | 0.540 |
Why?
|
| Cell Nucleus | 5 | 2011 | 602 | 0.520 |
Why?
|
| Signal Transduction | 6 | 2020 | 2885 | 0.510 |
Why?
|
| Peptide Chain Elongation, Translational | 1 | 2015 | 11 | 0.510 |
Why?
|
| Synaptic Transmission | 3 | 2012 | 150 | 0.510 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2015 | 60 | 0.490 |
Why?
|
| Chromatin | 1 | 2020 | 592 | 0.490 |
Why?
|
| Repressor Proteins | 4 | 2017 | 336 | 0.480 |
Why?
|
| Amino Acid Sequence | 9 | 2010 | 1580 | 0.480 |
Why?
|
| Motor Neurons | 1 | 2016 | 206 | 0.480 |
Why?
|
| Proteins | 2 | 2017 | 742 | 0.470 |
Why?
|
| Behavior, Animal | 1 | 2016 | 214 | 0.470 |
Why?
|
| Cell Line | 8 | 2012 | 2011 | 0.470 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2014 | 74 | 0.470 |
Why?
|
| Male | 16 | 2024 | 27470 | 0.460 |
Why?
|
| Insulin | 2 | 2012 | 687 | 0.460 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 2057 | 0.450 |
Why?
|
| Ribonucleoproteins | 2 | 2012 | 112 | 0.450 |
Why?
|
| Maze Learning | 2 | 2020 | 51 | 0.440 |
Why?
|
| Cognition | 1 | 2017 | 459 | 0.440 |
Why?
|
| Phosphoproteins | 2 | 2012 | 216 | 0.430 |
Why?
|
| Heartburn | 1 | 2012 | 3 | 0.430 |
Why?
|
| NF-kappa B | 2 | 2014 | 461 | 0.420 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2012 | 19 | 0.420 |
Why?
|
| Urban Health | 1 | 2012 | 43 | 0.420 |
Why?
|
| Body Patterning | 2 | 2011 | 85 | 0.420 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2025 | 132 | 0.410 |
Why?
|
| Poly(A)-Binding Proteins | 3 | 2007 | 5 | 0.410 |
Why?
|
| Spindle Apparatus | 2 | 2005 | 123 | 0.410 |
Why?
|
| Rats | 9 | 2013 | 1907 | 0.410 |
Why?
|
| Tight Junctions | 1 | 2012 | 19 | 0.400 |
Why?
|
| Cell Nucleolus | 2 | 2016 | 68 | 0.390 |
Why?
|
| Epithelium | 1 | 2012 | 96 | 0.390 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2012 | 82 | 0.380 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 68 | 0.380 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2011 | 299 | 0.380 |
Why?
|
| Progesterone | 3 | 2012 | 157 | 0.370 |
Why?
|
| Adenosine Triphosphate | 1 | 2012 | 287 | 0.370 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2013 | 75 | 0.340 |
Why?
|
| Binding, Competitive | 1 | 2009 | 102 | 0.340 |
Why?
|
| Endoplasmic Reticulum | 1 | 2010 | 167 | 0.330 |
Why?
|
| Mitochondria | 1 | 2012 | 333 | 0.330 |
Why?
|
| Female | 19 | 2019 | 30789 | 0.330 |
Why?
|
| Codon, Terminator | 1 | 2009 | 21 | 0.320 |
Why?
|
| Peptide Chain Termination, Translational | 1 | 2009 | 16 | 0.320 |
Why?
|
| Genes, p53 | 1 | 2008 | 53 | 0.310 |
Why?
|
| Growth Hormone | 1 | 2008 | 19 | 0.310 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2008 | 22 | 0.310 |
Why?
|
| RNA 3' Polyadenylation Signals | 1 | 2008 | 2 | 0.300 |
Why?
|
| Membrane Proteins | 2 | 2012 | 842 | 0.300 |
Why?
|
| Cell Extracts | 1 | 2008 | 25 | 0.300 |
Why?
|
| Neoplasms | 3 | 2014 | 1227 | 0.300 |
Why?
|
| RNA, Small Interfering | 5 | 2020 | 850 | 0.290 |
Why?
|
| RNA Transport | 2 | 2004 | 29 | 0.290 |
Why?
|
| Cell Movement | 3 | 2017 | 421 | 0.290 |
Why?
|
| Liver | 1 | 2012 | 783 | 0.290 |
Why?
|
| Protein Kinases | 2 | 2009 | 139 | 0.280 |
Why?
|
| Calcium | 1 | 2010 | 552 | 0.280 |
Why?
|
| Aurora Kinases | 5 | 2005 | 10 | 0.280 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 1124 | 0.270 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2006 | 15 | 0.270 |
Why?
|
| Ovarian Follicle | 1 | 2006 | 39 | 0.270 |
Why?
|
| In Vitro Techniques | 4 | 2009 | 474 | 0.270 |
Why?
|
| Receptors, AMPA | 1 | 2006 | 41 | 0.270 |
Why?
|
| Calcineurin | 1 | 2006 | 42 | 0.270 |
Why?
|
| Brain Ischemia | 1 | 2010 | 403 | 0.270 |
Why?
|
| Energy Metabolism | 1 | 2008 | 348 | 0.260 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 3 | 2002 | 29 | 0.260 |
Why?
|
| Extinction, Psychological | 1 | 2006 | 14 | 0.260 |
Why?
|
| Lipopolysaccharides | 2 | 2022 | 644 | 0.250 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2006 | 158 | 0.250 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2005 | 71 | 0.250 |
Why?
|
| Drosophila Proteins | 3 | 2014 | 681 | 0.250 |
Why?
|
| Cyclin B1 | 4 | 2008 | 9 | 0.250 |
Why?
|
| Nuclear Proteins | 2 | 2012 | 759 | 0.240 |
Why?
|
| Gene Expression | 3 | 2015 | 807 | 0.240 |
Why?
|
| Embryo, Nonmammalian | 2 | 2002 | 170 | 0.240 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2023 | 3 | 0.230 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2023 | 10 | 0.230 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2004 | 57 | 0.230 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2004 | 41 | 0.220 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2009 | 357 | 0.220 |
Why?
|
| Carrier Proteins | 2 | 2006 | 709 | 0.220 |
Why?
|
| Mammary Glands, Animal | 2 | 2015 | 79 | 0.220 |
Why?
|
| Cell Membrane | 1 | 2005 | 489 | 0.210 |
Why?
|
| Nerve Net | 1 | 2024 | 94 | 0.210 |
Why?
|
| Disease | 2 | 2015 | 26 | 0.210 |
Why?
|
| DNA Methylation | 1 | 2025 | 274 | 0.210 |
Why?
|
| Ovary | 1 | 2003 | 96 | 0.210 |
Why?
|
| Adenosine Monophosphate | 1 | 2002 | 26 | 0.200 |
Why?
|
| Peptide Initiation Factors | 1 | 2002 | 32 | 0.200 |
Why?
|
| Cell Line, Tumor | 2 | 2017 | 1366 | 0.200 |
Why?
|
| Inflammation | 2 | 2022 | 1100 | 0.200 |
Why?
|
| Dinucleotide Repeats | 1 | 2021 | 9 | 0.200 |
Why?
|
| Drosophila melanogaster | 2 | 2008 | 480 | 0.200 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 696 | 0.190 |
Why?
|
| Nervous System Diseases | 2 | 2014 | 95 | 0.190 |
Why?
|
| Zinc Fingers | 1 | 2002 | 95 | 0.190 |
Why?
|
| Oligonucleotides | 1 | 2023 | 206 | 0.190 |
Why?
|
| Learning | 2 | 2017 | 171 | 0.190 |
Why?
|
| RNA 5' Terminal Oligopyrimidine Sequence | 1 | 2020 | 1 | 0.180 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 2020 | 8 | 0.180 |
Why?
|
| Obsessive Behavior | 1 | 2020 | 2 | 0.180 |
Why?
|
| Injections, Intraventricular | 1 | 2020 | 17 | 0.180 |
Why?
|
| Peptide Elongation Factor 2 | 1 | 2020 | 4 | 0.180 |
Why?
|
| Avoidance Learning | 1 | 2020 | 22 | 0.180 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2020 | 30 | 0.180 |
Why?
|
| Isoenzymes | 1 | 2020 | 134 | 0.180 |
Why?
|
| HeLa Cells | 1 | 2021 | 527 | 0.170 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 131 | 0.170 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2011 | 106 | 0.170 |
Why?
|
| Nervous System | 2 | 2014 | 69 | 0.170 |
Why?
|
| Lysine | 1 | 2020 | 75 | 0.170 |
Why?
|
| GC Rich Sequence | 1 | 2019 | 3 | 0.160 |
Why?
|
| Gene Knockdown Techniques | 2 | 2011 | 193 | 0.160 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2014 | 96 | 0.160 |
Why?
|
| Cerebral Cortex | 1 | 2020 | 253 | 0.160 |
Why?
|
| Quality Control | 1 | 2019 | 70 | 0.160 |
Why?
|
| DNA-Binding Proteins | 2 | 2004 | 1128 | 0.160 |
Why?
|
| Cell Division | 3 | 2007 | 441 | 0.150 |
Why?
|
| Exoribonucleases | 1 | 2017 | 25 | 0.140 |
Why?
|
| Microsatellite Repeats | 1 | 2017 | 37 | 0.140 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2017 | 50 | 0.140 |
Why?
|
| Ataxia | 1 | 2017 | 23 | 0.140 |
Why?
|
| Recombinant Proteins | 2 | 2009 | 692 | 0.140 |
Why?
|
| Histones | 1 | 2020 | 463 | 0.140 |
Why?
|
| Spinal Nerves | 1 | 2016 | 5 | 0.140 |
Why?
|
| RNA Interference | 2 | 2012 | 588 | 0.140 |
Why?
|
| Sequence Alignment | 2 | 2008 | 290 | 0.130 |
Why?
|
| Genes, Lethal | 1 | 2016 | 41 | 0.130 |
Why?
|
| Electric Stimulation | 2 | 2008 | 139 | 0.130 |
Why?
|
| Brain Chemistry | 2 | 2007 | 80 | 0.130 |
Why?
|
| Transfection | 3 | 2007 | 671 | 0.130 |
Why?
|
| Neuromuscular Junction | 1 | 2016 | 82 | 0.130 |
Why?
|
| Caenorhabditis elegans Proteins | 2 | 2014 | 396 | 0.130 |
Why?
|
| Protein Domains | 1 | 2016 | 138 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2010 | 502 | 0.130 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 59 | 0.120 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2007 | 254 | 0.120 |
Why?
|
| Blotting, Western | 2 | 2006 | 594 | 0.120 |
Why?
|
| Gene Library | 2 | 2005 | 99 | 0.120 |
Why?
|
| Protein Transport | 2 | 2007 | 393 | 0.120 |
Why?
|
| Embryonic Development | 1 | 2016 | 136 | 0.120 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 195 | 0.120 |
Why?
|
| RNA, Transfer | 1 | 2015 | 76 | 0.120 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 162 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2013 | 569 | 0.110 |
Why?
|
| Amyloid | 1 | 2014 | 61 | 0.110 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 3 | 2002 | 30 | 0.110 |
Why?
|
| Memory, Short-Term | 1 | 2013 | 59 | 0.110 |
Why?
|
| Cell Differentiation | 2 | 2011 | 1290 | 0.110 |
Why?
|
| NADH Dehydrogenase | 1 | 2012 | 5 | 0.110 |
Why?
|
| Philadelphia | 1 | 2012 | 16 | 0.110 |
Why?
|
| Mutagenesis, Insertional | 1 | 2013 | 91 | 0.110 |
Why?
|
| NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2012 | 3 | 0.110 |
Why?
|
| Electron Transport Complex I | 1 | 2012 | 16 | 0.110 |
Why?
|
| Binding Sites | 2 | 2013 | 873 | 0.100 |
Why?
|
| Calcium Channel Blockers | 1 | 2012 | 56 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 275 | 0.100 |
Why?
|
| Gastroesophageal Reflux | 1 | 2012 | 77 | 0.100 |
Why?
|
| Morphogenesis | 1 | 2012 | 112 | 0.100 |
Why?
|
| Claudin-3 | 1 | 2012 | 2 | 0.100 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2012 | 7 | 0.100 |
Why?
|
| Claudins | 1 | 2012 | 5 | 0.100 |
Why?
|
| Genomic Imprinting | 2 | 2003 | 49 | 0.100 |
Why?
|
| Caco-2 Cells | 1 | 2012 | 65 | 0.100 |
Why?
|
| Protein Stability | 1 | 2012 | 82 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 580 | 0.100 |
Why?
|
| Dietary Fats | 1 | 2012 | 204 | 0.100 |
Why?
|
| Energy Intake | 1 | 2012 | 213 | 0.100 |
Why?
|
| Population Surveillance | 1 | 2012 | 205 | 0.100 |
Why?
|
| Cell Polarity | 1 | 2012 | 110 | 0.100 |
Why?
|
| Heterozygote | 1 | 2012 | 168 | 0.100 |
Why?
|
| Immunoprecipitation | 2 | 2013 | 116 | 0.090 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 72 | 0.090 |
Why?
|
| Protein Multimerization | 1 | 2012 | 163 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 202 | 0.090 |
Why?
|
| Receptors, Ionotropic Glutamate | 1 | 2010 | 3 | 0.090 |
Why?
|
| Tetrodotoxin | 1 | 2010 | 8 | 0.090 |
Why?
|
| Sodium Channel Blockers | 1 | 2010 | 10 | 0.090 |
Why?
|
| N-Methylaspartate | 1 | 2010 | 14 | 0.090 |
Why?
|
| Diet, High-Fat | 1 | 2012 | 159 | 0.090 |
Why?
|
| Life Style | 1 | 2012 | 328 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 3 | 2013 | 421 | 0.090 |
Why?
|
| Dogs | 1 | 2012 | 313 | 0.090 |
Why?
|
| Mammals | 2 | 2002 | 203 | 0.090 |
Why?
|
| Alcohol Drinking | 1 | 2012 | 299 | 0.090 |
Why?
|
| Guanosine | 1 | 2009 | 10 | 0.090 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2009 | 14 | 0.090 |
Why?
|
| Motor Activity | 1 | 2012 | 342 | 0.080 |
Why?
|
| NIH 3T3 Cells | 1 | 2009 | 96 | 0.080 |
Why?
|
| Analysis of Variance | 2 | 2013 | 576 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 3 | 2013 | 351 | 0.080 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2009 | 19 | 0.080 |
Why?
|
| Retinal Ganglion Cells | 1 | 2009 | 26 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 522 | 0.080 |
Why?
|
| Glucose | 1 | 2012 | 444 | 0.080 |
Why?
|
| Substrate Specificity | 1 | 2009 | 321 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2013 | 940 | 0.080 |
Why?
|
| Prevalence | 1 | 2012 | 1278 | 0.080 |
Why?
|
| Body Mass Index | 1 | 2012 | 891 | 0.080 |
Why?
|
| Electrophysiology | 1 | 2008 | 89 | 0.080 |
Why?
|
| Insulin Resistance | 1 | 2012 | 403 | 0.080 |
Why?
|
| Axons | 1 | 2009 | 120 | 0.080 |
Why?
|
| Drosophila | 1 | 2011 | 419 | 0.080 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2009 | 113 | 0.080 |
Why?
|
| RNA Precursors | 1 | 2008 | 74 | 0.070 |
Why?
|
| Eukaryotic Initiation Factor-4G | 1 | 2007 | 5 | 0.070 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2008 | 67 | 0.070 |
Why?
|
| Smoking | 1 | 2012 | 830 | 0.070 |
Why?
|
| Adenine | 1 | 2008 | 46 | 0.070 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 533 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2008 | 306 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-mos | 1 | 2007 | 3 | 0.070 |
Why?
|
| Nucleotidyltransferases | 1 | 2008 | 54 | 0.070 |
Why?
|
| F-Box Proteins | 1 | 2007 | 15 | 0.070 |
Why?
|
| Oogenesis | 1 | 2007 | 45 | 0.070 |
Why?
|
| Virus Cultivation | 1 | 2007 | 17 | 0.070 |
Why?
|
| Synaptosomes | 1 | 2007 | 16 | 0.070 |
Why?
|
| Bone Morphogenetic Protein 15 | 1 | 2006 | 8 | 0.070 |
Why?
|
| Growth Differentiation Factor 9 | 1 | 2006 | 9 | 0.070 |
Why?
|
| Isotope Labeling | 1 | 2007 | 68 | 0.070 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2006 | 12 | 0.070 |
Why?
|
| Amino Acid Substitution | 1 | 2007 | 253 | 0.070 |
Why?
|
| Proteomics | 1 | 2008 | 252 | 0.070 |
Why?
|
| Cohort Studies | 1 | 2012 | 2435 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 52 | 0.070 |
Why?
|
| Neural Crest | 1 | 2006 | 29 | 0.070 |
Why?
|
| Spatial Behavior | 1 | 2006 | 7 | 0.070 |
Why?
|
| Genes, Reporter | 1 | 2007 | 243 | 0.070 |
Why?
|
| DNA Primers | 1 | 2006 | 291 | 0.070 |
Why?
|
| Aurora Kinase A | 1 | 2005 | 3 | 0.070 |
Why?
|
| Molecular Chaperones | 1 | 2006 | 97 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2009 | 415 | 0.070 |
Why?
|
| Vertebrates | 1 | 2006 | 41 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2006 | 97 | 0.060 |
Why?
|
| Protein Array Analysis | 1 | 2006 | 21 | 0.060 |
Why?
|
| Phosphoamino Acids | 1 | 2005 | 1 | 0.060 |
Why?
|
| Phosphoserine | 1 | 2005 | 10 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 65 | 0.060 |
Why?
|
| Luminescent Proteins | 2 | 2003 | 129 | 0.060 |
Why?
|
| Staphylococcal Protein A | 1 | 2005 | 5 | 0.060 |
Why?
|
| Cell Culture Techniques | 1 | 2007 | 176 | 0.060 |
Why?
|
| Cerebellum | 1 | 2006 | 94 | 0.060 |
Why?
|
| Quality of Life | 1 | 2012 | 1108 | 0.060 |
Why?
|
| Serine | 1 | 2005 | 83 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2008 | 377 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2006 | 208 | 0.060 |
Why?
|
| Substance-Related Disorders | 1 | 2012 | 689 | 0.060 |
Why?
|
| Spinal Cord | 1 | 2006 | 195 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2004 | 111 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2004 | 166 | 0.060 |
Why?
|
| Antimetabolites | 1 | 2004 | 17 | 0.060 |
Why?
|
| Organ Culture Techniques | 1 | 2004 | 70 | 0.060 |
Why?
|
| Gonadotropins, Equine | 1 | 2004 | 2 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 291 | 0.060 |
Why?
|
| Sirolimus | 1 | 2004 | 72 | 0.060 |
Why?
|
| Action Potentials | 1 | 2004 | 103 | 0.060 |
Why?
|
| Prophase | 1 | 2003 | 13 | 0.050 |
Why?
|
| Threonine | 1 | 2003 | 14 | 0.050 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2003 | 42 | 0.050 |
Why?
|
| Antibody Specificity | 1 | 2003 | 99 | 0.050 |
Why?
|
| Molecular Motor Proteins | 1 | 2003 | 34 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2006 | 1219 | 0.050 |
Why?
|
| Metaphase | 1 | 2002 | 35 | 0.050 |
Why?
|
| Ubiquitins | 1 | 2002 | 41 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2004 | 353 | 0.050 |
Why?
|
| Microtubules | 1 | 2003 | 211 | 0.050 |
Why?
|
| Transcriptional Activation | 1 | 2002 | 188 | 0.050 |
Why?
|
| Response Elements | 1 | 2001 | 42 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 453 | 0.050 |
Why?
|
| Time Factors | 1 | 2008 | 3564 | 0.050 |
Why?
|
| Insect Proteins | 1 | 2001 | 79 | 0.050 |
Why?
|
| Mitosis | 1 | 2002 | 207 | 0.040 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2004 | 418 | 0.040 |
Why?
|
| Codon, Initiator | 1 | 2017 | 11 | 0.040 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2017 | 9 | 0.040 |
Why?
|
| Frameshifting, Ribosomal | 1 | 2017 | 7 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 2017 | 82 | 0.040 |
Why?
|
| Middle Aged | 1 | 2012 | 16227 | 0.030 |
Why?
|
| Adult | 1 | 2012 | 15726 | 0.030 |
Why?
|
| Mutation | 1 | 2003 | 2424 | 0.030 |
Why?
|
| Anisomycin | 1 | 2013 | 6 | 0.030 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2013 | 25 | 0.030 |
Why?
|
| Biotinylation | 1 | 2013 | 38 | 0.030 |
Why?
|
| Glycine | 1 | 2013 | 45 | 0.030 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2013 | 24 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 161 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2011 | 151 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 219 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2009 | 215 | 0.020 |
Why?
|
| Plasmids | 1 | 2009 | 280 | 0.020 |
Why?
|
| Rabbits | 1 | 2007 | 330 | 0.020 |
Why?
|
| Sensory Deprivation | 1 | 2001 | 4 | 0.010 |
Why?
|
| Rats, Long-Evans | 1 | 2001 | 21 | 0.010 |
Why?
|
| Darkness | 1 | 2001 | 22 | 0.010 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2001 | 19 | 0.010 |
Why?
|
| Visual Cortex | 1 | 2001 | 27 | 0.010 |
Why?
|
| Photic Stimulation | 1 | 2001 | 90 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2001 | 98 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2000 | 178 | 0.010 |
Why?
|